I believe deeply that every American should have access to quality and affordable healthcare.

It’s 2020, and the Administration is still fighting to gut the Affordable Care Act. With continued attacks on the protections for people with pre-existing conditions and promoting plans with higher premiums, they have worked to make it easier for insurance companies to make money off of consumers rather than making sure people are protected. Worse, in June 2020, the Administration asked the Supreme Court to strike down the entire Affordable Care Act, which if overturned could strip millions of Americans of healthcare. That is simply unacceptable for the 130 million Americans with pre-existing conditions — including the more than 315,000 residents in our district.

In my first term, I’ve fought to make sure all Americans have access to affordable healthcare coverage, stabilize the healthcare marketplace, and protect coverage for pre-existing conditions.

I’m committed to lowering the cost of healthcare throughout the entire system, including lowering the cost of prescription drugs, requiring parity of treatment costs, and ensuring that no patient gets a bill—from a hospital, a pharmacy, or otherwise—that they didn’t expect. We need transparency and fairness throughout the healthcare system.

There is strong support for lowering the cost of prescription drugs and we need leaders who will work to deliver relief to Americans as quickly as possible. I helped write landmark legislation that passed in the House to lower the cost of prescription drugs for New Jerseyans and invest in the life sciences industry in our state. Our life sciences industry leads the world in development of treatments for cancer, infertility, and rare diseases. I’ve also supported legislation that passed in the House to enable more affordable generic prescription drugs to come to market sooner, one of the best ways to reduce drug prices for consumers.

The bipartisan Lower Drug Costs Now Act of 2019 (H.R. 3) that passed in the House gives Medicare the power to negotiate directly with drug companies and create an out-of-pocket limit on prescription drug costs for Medicare beneficiaries. I successfully included my legislation in H.R. 3 to direct a $10 billion investment in the National Institutes of Health for cancer, rare diseases, and antibiotic resistance research so that we can continue to develop life-saving drugs while at the same time bringing down prescription drug prices for consumers. Savings from H.R. 3 will be used to fund this $10 billion investment.

During the COVID-19 pandemic, I’ve worked to keep New Jersey residents and frontline workers safe. We passed the bipartisan CARES Act which expanded funding for testing, production of PPE here at home, and provided millions to our hospitals and community health centers in NJ-11. I fought to get federal resources to New Jersey to support nursing homes and other long-term care facilities in our community. I am also leading several bipartisan bills to expand access to telehealth services that have been so important for residents during the COVID-19 pandemic.